Nanosecond laser treatment for dry macular degeneration. Agerelated macular degeneration amd in its early stages may be reversed with laser treatment. Preventing progression in nonexudative agerelated macular. Nov 07, 2016 agerelated macular degeneration amd in its early stages may be reversed with laser treatment. Nanosecond laser trial the centre for eye research australia is conducting a world first randomised controlled trial of a new laser treatment for agerelated macular degeneration amd. Purpose the laser intervention in early stages of agerelated macular degeneration lead study is an investigation of the safety and efficacy of subthreshold nanosecond laser treatment to slow. A new doubleblind, randomized clinical trial is currently underway at the center for eye research australia cera to determine whether the 2rt nanosecond laser manufactured by ellex. The 2rt nanosecond laser system uses a laser pulse that lasts 3 ns to target the macular at the back of the eye. Nanosecond laser therapy reverses pathologic and molecular changes in agerelated macular degeneration without retinal damage. New laser therapy helps slow macular degeneration sciencedaily.
Tom spurling, managing director of ellex, says that a finely tuned laser fires an incredibly short burst of light that agitates the structures in the eye to trigger a natural, cellularlevel healing response. Purpose there is an urgent need for a more effective intervention to slow or prevent progression of agerelated macular degeneration amd from its early stages to visionthreatening late complications. Wet macular degeneration is called wet because the blood vessels that invade the macular eye area leak fluid and blood causing harm to cellular parts of the eye. A highly anticipated trial using nanosecond laser technology to slow the progression of agerelated macular degeneration amd has yielded promising results the laser intervention in early agerelated macular degeneration lead trial studied 300 people with amd and compared the disease progression of those treated with the laser with those who were not. Subthreshold nanosecond laser intervention in intermediate. Robyn h guymer, zhichao wu, lauren ab hodgson, emily caruso, kate h brassington, nicole tindill, khin zaw aung, myra b mcguinness, erica l fletcher. A breakthrough treatment approach, ellex 2rt retinal rejuvenation therapy retains the therapeutic benefits of laser therapy whilst eliminating the thermal tissue damage inherent in conventional retinal photocoagulation. The laser intervention in early stages of agerelated macular degeneration lead study is a 36month, multicenter, randomized, shamcontrolled trial conducted from 20122015 of 292 participants with bilateral soft drusen, aka intermediate amd iamd, who underwent q 6month treatment with subthreshold nanosecond laser snl or sham treatment to the study eye. Laser photocoagulation for agerelated macular degeneration. Answer a twostep treatment in which a lightsensitive drug visudyne is used to damage the abnormal blood vessels.
If youve got the dry form now, its important to keep a check on your vision. A highly anticipated trial using nanosecond laser technology to slow the progression of agerelated macular degeneration amd has yielded promising results the laser intervention in early age. Subthreshold nanosecond laser snl treatment in intermediate. Two hundred ninetytwo participants with bilateral large drusen and without oct signs of atrophy. Laser therapy for macular degeneration enhanced vision. Currently there is no cure for this type of macular degeneration. Kaplanmeier failure plot showing progression to late agerelated macular degeneration for the subthreshold nanosecond laser snl and sham treatment groups separately. Laser treatments are sometimes helpful to limit damage to the macular although lasik eye surgery is not safe nor. Some people with the dry form of amd can develop the wet form.
It is hoped this new treatment will slow or reverse the effects of dry macular degeneration, one of the most common causes of vision loss in the aging population. Pdf subthreshold nanosecond laser intervention in age. The study also showed evidence that nanosecond laser treatment in one eye can also produce positive effects in the other untreated eye. The laser intervention in early stages of agerelated macular degeneration lead study 1 is a 36month, multicenter, randomized, sham.
The laser intervention in early stages of agerelated macular degeneration lead study is a 36month, multicenter, randomized, sham. The purpose of the study is to determine whether 2rt nanosecond laser therapy slows the progression to advanced agerelated macular degeneration. Have laser eye surgery if i have macular degeneration. Using a new lowenergy, highspeed laser, the symptoms of agerelated macular degeneration were reduced. This study details the capacity of nanosecond laser. Subthreshold nanosecond laser intervention in agerelated macular degeneration.
Laser treatment of drusen to prevent progression to advanced. The laser intervention in early stages of agerelated macular degeneration lead study is a world. New nanosecond laser treatment alleviates macular degeneration. The aim of this study was to investigate the effects of laser treatment in humans and mice. The safety, changes in fundus characteristics and macular function in a cohort of participants with bilateral intermediate amd are reported. Subthreshold nanosecond laser snl treatment has shown promise in preclinical studies and a pilot study in intermediate amd iamd. Subthreshold nanosecond laser intervention in agerelated.
Tom spurling, managing director of ellex, says that a finely tuned laser fires an incredibly short. Laser photocoagulation is a type of laser surgery for the eyes. A for participants without coexisting reticular pseudodrusen rpd at baseline n. It is done to treat agerelated macular degeneration amd. In addition to effectively treating the disease, the new laser treatment spared retinal tissue, where current laser treatments tend to damage it. Participants will be randomized to receive either the 2rt laser or a sham laser. Nanosecondlaser application in intermediate amd 12month results of fundus appearance and macular function. Currently, the laser intervention in early agerelated macular degeneration study lead, a multicentre randomised clinical trial using a nanosecond laser to investigate progression of amd in 240. Macular degeneration without retinal damage, the faseb journal 29, no. Nanosecond laser treatment for agerelated macular degeneration does not induce focal vision loss or new vessel growth in the retina. Laser intervention in early agerelated macular degeneration study lead the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. The laser intervention in early stages of agerelated macular degeneration lead study is a 36month, multicenter, randomized, shamcontrolled trial.
Nov 19, 2014 medical xpress a new, low impact low energy laser treatment for patients with early agerelated macular degeneration amd has produced positive results by reducing indicators of the disease. Currently, the laser intervention in early agerelated macular degeneration study lead, a multicentre randomised clinical trial using a nanosecond laser to investigate progression of amd in 240 participants, is underway. Laser intervention in early agerelated macular degeneration. The laser intervention in early stages of agerelated macular degeneration lead study is an investigation of the safety and efficacy of subthreshold nanosecond laser treatment to slow the progression of intermediate agerelated macular degeneration amd. The retina is the layer of cells in the back of your eye that converts light into electrical signals. A new nanosecond laser used to treat agerelated macular degeneration amd will be officially launched in spain next month. The centre for eye research australia is conducting a world first randomised controlled trial of a new laser treatment for agerelated macular degeneration amd. Nov 20, 2014 agerelated macular degeneration vision loss changes have bee reduced by a new type of laser treatment, which does not damage the retina. Amd is a condition that can lead to loss of vision. The laser intervention in early stages of agerelated macular degeneration lead study is a 36month, multicenter, randomized, shamcontrolled trial conducted from 20122015 of 292. Agerelated macular degeneration amd is a significant cause of vision loss in aging patients. Listing a study does not mean it has been evaluated by the u. What is laser photocoagulation for agerelated macular degeneration.
Guymer, mbbs, phd, zhichao wu, bappscoptom, phd, lauren ab. A new doubleblind, randomized clinical trial is currently underway at the center for eye research australia cera to determine whether the 2rt nanosecond laser manufactured by ellex medical lasers ltd can be utilized to slow the progression of agerelated macular degeneration in patients with early stage amd. This was the conclusion of a study from the university of. Subthreshold, nanosecond pulsed laser treatment shows promise as a treatment for agerelated macular degeneration amd. A new nanosecond laser treatment for dry macular degeneration is being tested at the australian centre for eye research. Estimated hazard ratio hr is from a model adjusted for baseline covariates in the intentiontotreat set n 292.
Agerelated macular degeneration in its early stages may be. Agerelated macular degeneration vision loss changes have bee reduced by a new type of laser treatment, which does not damage the retina. Professor robyn guymer, the lead 2rt principal investigator states. A breakthrough treatment approach, ellex 2rt retinal rejuvenation therapy retains the therapeutic benefits of laser therapy whilst eliminating the thermal tissue damage inherent in conventional retinal. Nov 19, 2014 the study also showed evidence that nanosecond laser treatment in one eye can also produce positive effects in the other untreated eye. This study details the capacity of nanosecond laser treatment to reduce drusen and thin bm while maintaining retinal structure. The lead randomized controlled clinical trial robyn h. In addition to effectively treating the disease, the new laser treatment spared retinal tissue. Professor robyn guymer, the lead 2rt principal investigator states, our research shows that application of 2rt treatment is safe and painless, and results in both improved visual function. Blog new laser treatment helps to reduce the rate of. Developed by australian company ellex, the 2rt laser will be launched at the. Agerelated macular degeneration amd is a leading cause of vision loss, characterized by drusen deposits and thickened bruchs membrane bm.
At present i have 2020 vision is what they are telling me. A highly anticipated trial using nanosecond laser technology to slow the progression of agerelated macular degeneration amd has yielded promising results. The laser intervention in early stages of agerelated macular degeneration lead study is an investigation of the safety and efficacy of subthreshold nanosecond laser treatment to slow the. Developed by australian company ellex, the 2rt laser will be launched at the european society of cataract and refractive surgeons escrs congress in barcelona in september. Medical xpress a new, low impact low energy laser treatment for patients with early agerelated macular degeneration amd has produced positive results by reducing indicators of the. How does photodynamic laser therapy treat agerelated macular. Using an animal model that recapitulates the thickened bm seen in amd, the effect of nanosecond laser treatment on bm thickness and rpechoroidal gene expression was also characterized. It is hoped this new treatment will slow or reverse the effects of.
Laser treatment reverses effects of early agerelated macular. Retina rejuvenation therapy for diabetic macular edema. How does photodynamic laser therapy treat agerelated macular degeneration. Mar 22, 2019 jobling ai, guymer rh, vessey ka, et al. Nanosecond laser therapy reverses pathologic and molecular. Subthreshold nanosecond laser intervention in agerelated macular degeneration the lead randomized controlled clinical trial. The recent development of the nanosecond laser 2rt, ellex, pty ltd offers great promise as a treatment that may reduce progression of the disease. Macular degeneration may respond to new laser therapy.
631 777 133 732 276 590 1316 613 887 1152 612 524 1522 354 1337 857 684 44 108 1041 120 770 16 1057 818 367 858 1458 1500 1504 1077 1364 215 415 275 228 1220 83 1379 1187 1128 1075 1303